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36 patients with articular syndrome. The following parameters were evaluated: anthropometric data (height, body mass, body mass index, waist circumference), lipid spectrum, glycohemoglobin, nonspecific markers of inflammation, daily profile of arterial pressure. Results. In the group with comorbid pathology higher average values of body mass were recor ded -115. 8 [60;140] In patients with combined metabolic and articular syndromes higher values of body mass and systolic arterial pressure were identified. Based on the laboratory findings, parameters of ch olesterol and erythrocyte sedimentation rate were higher in patients with comorbid co ndition than in those with the isolated pathologies.
Keywords: metabolic syndrome, articular syndrome, comorbidity, rheumatic diseases. ______________________________________________________________________________ Metabolic syndrome (MS) is characterized by derangement of all kinds of metabolism, increase in mass of visceral fat, hyperinsulinemia and insulin resistance, and elevation of the arterial pressure. This pathology affects about 20-35% of population of Russia [1] . Also common in Russian Federation are rheumatic diseases. According to the data of Health Ministry, 15 mln individuals with diseases of this group are recorded [2] . Their main manifestation is articular syndrome (AS) which is a complex of symptoms resulting from damage to the anatomical structures of joints [3, 4] . Patients with metabolic disorders are more inclined to development of the articular pathology. In recent 10 years increased incidence of comorbidity of MS and AS has been noted [5] [6] [7] . A high incidence of a combination of these syndromes can be attributed to common risk factors and similar pathogenesis. Contributing factors to these conditions are low social-economic status, hypodynamia, excessive body mass, arterial hypertension, insulin resistance and hyperinsulinemia, and also hereditary predisposition and genetic anomalies [8] . Such processes as chronic inflammation, oxidative stress and metabolic disorders also lead to these pathologies [5] .
Aim of work -to identify clinical and laboratory peculiarities of a combined clinical course of MS and AS.  existence of rheumatic disease with damage to knee joints -gonarthrosis (except the 4th stage according to KellgrenLawrence), psoriatic, rheumatoid and gouty arthritis;
Materials and Methods
 diagnosis of the disease stated by a rheumatologist not later than 3 months before the study;
 no administration of intraarticular injections within 1 month before the study, and cancellation of nonsteroid anti-inflammatory drugs 1 week before the study.
Criteria for exclusion were the following conditions: 4th stage gonarthrosis according to Kellgren-Lawrence, endocrinopathies including diabetes mellitus, chronic disease of kidney, detachment of retina, diabetic foot, ischemic heart disease, arrhythmias of different genesis, hematological and neoplastic diseases, pregnancy, lactation period, intake of hypolipidemic drugs. Besides, into the research were not included patients with viral and bacterial infections, congenital pathologies of the musculo-skeletal system and traumatic lesions of the knee joints, and with mental disorders.
Participation in the research was voluntary. All respondents signed Informed consent approved by Ethical Committee of RyazSMU of Health Ministry of Russia.
In the process of work anthropometric parameters were measured: height, weight, body mass index (BMI) and waist circumference. Laboratory parameters were evaluated reflecting the condition of lipid and carbohydrate metabolism -cholesterol (ChS), low density lipoproteins (LDL), high density lipoproteins (HDL), triglycerides (TG), glycohemoglobin (GH), and non-specific markers of inflammation -erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), seromucoid. Daily monitoring of arterial pressure was conducted.
The height was measured using vertical height meter, and weight -using floor scales. Waist circumference was measured with a centimeter tape in a vertical position. BMI was calculated from the formula: body mass (kg)/height (cm) 2 . Laboratory analyses were carried out on a semiautomatic analyzer ClimaMC-15. Glycohemoglobin was determined using analyzer of Statfax 4500 company. Daily monitoring of arterial pressure was conducted on МД-01-Дон monitor. Mathematical processing of the results was carried out using programs MS Excel 2012 and Statistica, version 10.0.
Results and Discussion The type and degree of obesity were identified in anthropometric examination of patients. The results are presented in Table 2 . (34.1%), I degree of obesity -in 18 individuals (40.9%), II degree -in 7 (15.9%), III degree -in 3 (9.1%). The average BMI in the 3 d group corresponded to the normal weight. However, 5 individuals had excessive body mass (13.8%), and 4 -I degree obesity (11.1%), but nevertheless, these patients had no abdominal obesity and metabolic disorders that excluded MS.
Thus, anthropometry revealed significant differences in body mass: in the group of combined MS and AS higher values of BMI were noted than in comparison groups (р≤0.05), as well as a tendency to increase in the waist circumference. It is known that the condition of fat and carbohydrate metabolism influences the course of MS and AS [1, 9] . Data of examination of lipid spectrum and parameters of glycohemoglobin are given in Table 3 . In evaluation of lipid profile the average values of cholesterol, LDL and triglycerides in all groups did not cross the reference limits. In the 1 st and 2 nd groups increase in the average values of total cholesterol and LDL was noted. In patients with comorbid pathology the average value of the total cholesterol was reliably higher than in individuals with AS (р<0.05). In all groups median HbА1С was within the reference range, but patients with the combined pathology showed a tendency to a higher value of this parameter.
According to literature data, metabolic disorders in MS and in rheumatic pathology are promoted by systemic chronic inflammation [10, 11] . Such parameters as CRP, seromucoid and ESR reflect severity and activity of the inflammatory process. Results of study of these parameters are given in Table 4 . Median ESR in the group of comorbid pathology was reliably higher than in the group with MS (р<0.05). The average value of CRP in the 1 st group was higher than in comparison groups, however, no statistically significant difference was obtained.
Arterial hypertension is a common symptom in MS and rheumatic diseases. It is induced by hyperinsulinemia, dyslipidemia, chronic inflammatory process, endothelial dysfunction, hyper reactivity of the sympathetic nervous system and activation of hypo- thalamic-pituitary-adrenal axis [12, 13] . In our work parameters of the average daily arterial pressure were evaluated (Table 5) . Thus, based on the data of some clinical and laboratory examinations, the peculiarities of combined course of MS and AS were identified. Patients with the comorbid pathology had higher BMI parameters. There was also found a tendency to increase in the waist circumference which is an indirect evidence of a more pronounced abdominal obesity in this group. The obtained results agree with the data of other authors who described a significant increase in body mass in individuals with MS and AC, as, for example, in gout [14] .
Analysis of lipid profile showed increase in the level of cholesterol and LDL in blood of patients with MS. Here, the extent of increase in cholesterol was significantly higher in comorbid pathology. The obtained data do not contradict the results of other studies. Derangement of lipid metabolism is typical of all patients with MS [15] . Dyslipidemia is also commonly recorded in individuals with rheumatic pathology [16, 17] . In particular, the levels of cholesterol and LDL in patients with rheumatoid arthritis are noted to be increased before the onset of the disease [18] .
Evaluation of nonspecific markers of inflammation in the group with comorbid pathology revealed a more evident increase in ESR and the level of CRP indicating a high activity of inflammatory process. Similar changes were obtained in the works of other authors who studied these parameters in individuals with rheumatoid arthritis, and with combination of osteoarthrosis, arterial hypertension and obesity [10, 19] .
Higher parameters of systolic arterial pressure were recorded in patients with MS and in its combination with AS. These results were anticipated since arterial hypertension is the main component of MS. For individuals with rheumatic pathology elevated blood pressure is a confounding factor that enhances immunoinflammatory and autoimmune response in an organism [13, 20] . Conclusions 1. In patients with metabolic and articular syndromes higher parameters of body mass were identified.
2. Combination of the given syndromes is associated with a more pronounced hypercholesterolemia.
3. Comorbid pathology is characterized by accelerated erythrocyte sedimentation rate which indicates high activity of a chronic inflammatory process.
4. High level of systolic arterial pressure is more characteristic of metabolic syndrome and of its combination with articular pathology. 
